Emma Dunn

It helped ease the pain for participants in a small study.

A review of data suggests it’s safe for those with mild kidney impairment.

A recent review suggests metformin is the most popular for a reason, but newer drugs may challenge metformin’s market dominance.

Get to know this popular blood-sugar-lowering drug.

We take a closer look at a drug that helps combat insulin resistance. It comes with some risks, however.

A study finds the agency’s testing protocol for blockbuster devices slows down the process and leads to unnecessary testing.

New guidelines suggest that young people with Type 1 who discuss their diabetes online stay engaged in their self-care.

A pair of studies suggests that attending a pre-conception clinic can lead to a safer pregnancy for women with Type…

In a major trial, researchers are attempting to keep beta cells working longer in children at risk of Type 1…

And enter for a chance to win a Starbucks giftcard.

The recall is being undertaken because alarms in Dexcom’s CGM devices are reported to be faulty.

Researchers find that 25% of people with Type 1 suffered from moderate to severe diabetic ketoacidosis after bariatric surgery.

A trial reveals that Lucentis may be better than laser eye surgery at treating proliferative diabetic retinopathy, which causes blindness.

The Diabetes Scholars Foundation has provided opportunities for thousands.

Lilly CEO says insulin price increases are necessary to fund research.

It performed nearly as well as injectable glucagon in staving off hypoglycemia.

A recent audit of UK hospitals suggests that too many patients with diabetes receive substandard blood sugar control.

The move comes as health care companies rush to provide treatment options for the growing diabetes epidemic in China.